Exhalation Medical Technology

EMT was founded in 2011 for the purpose of carrying out research in exhaled breath markers. We seek to make testing for virus rapid, reliable and easy, providing instant results at Point of Care, requiring neither sample handing nor laboratory equipment. Our technology builds on the Inflammacheck®, which is the only device in the market designed to collect Exhaled Breath Condensate, EBC and test for compounds directly therein at Point of Care. We repurpose Inflammacheck® to enable screening for Corona in a similar procedure. To do so, we make an existing sensor platform specific to Corona by immobilizing a receptor to it to which the Corona virus has a very strong affinity. Thus, Corona is expected to bind to the sensor, thereby producing a measurable signal.